CORPUS CHRISTI - The compounding company at the center of the alleged tainted IVs investigation issued a response to attorney Thomas J. Henry's claims.
Specialty Compounding says testing by the pharmacy's independent lab and by federal and state agencies on samples of their calcium gluconate infusion product has not yet proven an association between Specialty Compounding's medication and the affected patients.
The company statement goes on to say that its top priority is patient safety and ensuring all recalled products are promptly returned to the pharmacy.
On Tuesday, Henry issued a statement saying he's investigating 10 deaths of patients who may have been exposed to the recalled medication.
The FDA had recalled the medications from the firm after reports that patients being treated at Corpus Christi area hospitals developed bacterial infections.